Why Merkel cell polyomavirus stays hidden inside cells
Mechanism For Merkel Cell Polyomavirus Persistence
This project looks at how Merkel cell polyomavirus hides inside human cells so it can persist and sometimes lead to Merkel cell carcinoma.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11254925 on NIH RePORTER |
What this research studies
Researchers will use high-resolution single-molecule imaging to watch viral proteins from Merkel cell polyomavirus bind to the virus's DNA and to see when replication starts. They will focus on the virus's Large T protein plus other viral and cellular factors that may change how the virus copies itself or stays dormant. The team will separate the virus's DNA-binding and replication activities from its effects on cell transcription to map the steps that maintain latency. These are laboratory experiments using viral genomes and purified components to reveal the molecular mechanisms of persistence.
Who could benefit from this research
Good fit: People with Merkel cell carcinoma or those known to carry Merkel cell polyomavirus would be the most relevant group to follow this work or be asked to provide tissue or samples.
Not a fit: People without MCPyV infection or with unrelated medical conditions are unlikely to receive direct benefit from this basic laboratory research in the near term.
Why it matters
Potential benefit: If successful, this work could point to new ways to block viral persistence and help prevent or treat Merkel cell carcinoma linked to MCPyV.
How similar studies have performed: Prior virology work has characterized parts of MCPyV biology, but real-time single-molecule visualization of Large T binding and helicase activity is a relatively new and less-tested approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Chang, Yuan — University of Pittsburgh at Pittsburgh
- Study coordinator: Chang, Yuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.